Core Technical Competencies


Baxter's groundbreaking work in the processing and separation of blood plasma and its components is at the foundation of many contemporary biologically derived therapies, including the treatment of hemophilia and primary immune deficiency.  Baxter also is involved in leading-edge research and development in recombinant therapeutics, vaccines and regenerative medicine.  Baxter offers unique capabilities in the production of genetically engineered therapies and vaccines in a variety of bacterial, yeast and mammalian cell culture systems; and protein-based processes to perform biological separation and purification.